Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical review 22: Therapeutic options in acromegaly.

× No keyword cloud information.

7 in total

1. Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly.

Authors: A Colao; P Marzullo; D Ferone; V Marinò; R Pivonello; C Di Somma; A Di Sarno; A Giaccio; G Lombardi
Journal: J Endocrinol Invest Date: 1999-01 Impact factor: 4.256

2. Experiences with octreotide in acromegaly.

Authors: J A O'Hare; F Abuaisha; T Cotter
Journal: Ir J Med Sci Date: 1993-02 Impact factor: 1.568

3. Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients.

Authors: P Marzullo; D Ferone; C Di Somma; R Pivonello; M Filippella; G Lombardi; A Colao
Journal: Pituitary Date: 1999 Impact factor: 4.107

4. A prospective multicenter octreotide dose response study in the treatment of acromegaly.

Authors: S Ezzat; D A Redelmeier; M Gnehm; A G Harris
Journal: J Endocrinol Invest Date: 1995-05 Impact factor: 4.256

5. Somatostatin cells in human somatotropic adenomas.

Authors: J Y Li; P Pagesy; M Berthet; O Racadot; M Kujas; J Racadot; F Peillon
Journal: Virchows Arch A Pathol Anat Histopathol Date: 1992

Review 6. Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours.

Authors: P Chanson; J Timsit; A G Harris
Journal: Clin Pharmacokinet Date: 1993-11 Impact factor: 6.447

7. Results of continuous long-term intravenous application of octreotide via an implantable pump system in acromegaly resistant to operative and X-ray therapy.

Authors: G Hildebrandt; J Zierski; G Csecsei; H W Mueller; H Stracke
Journal: Acta Neurochir (Wien) Date: 1992 Impact factor: 2.216

7 in total